-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Names & News
-
IASLC Spotlight: Basic and Translational Science Committee
From the VIKTOR platform to the upcoming IASLC Hot Topics meeting, Dr. Tom John discusses the committee’s long-term goals, ongoing projects, and future directions.
-
ILCN Editorial Board Member Appointed to the Thoracic Oncology Team at Winship Cancer Institute
Dr. Shirish Gadgeel has assumed new clinical and educational leadership roles at Emory University School of Medicine and the Winship Cancer Institute.
-
Multiple Institutions Welcome Renowned Lung Cancer Experts
Dartmouth Cancer Center and Temple Health announce incoming directors following the appointment of a new division chief of thoracic medical oncology at City of Hope earlier this year.
-
Heine H. Hansen Award Honors Prof. Filippo de Marinis
Prior to delivering the Heine H. Hansen Award Lecture at ELCC 2026, Dr. Antonio Passaro shared a personal tribute dedicated to his colleague and mentor, Prof. Filippo de Marinis.
-
Remembering the Life of Dr. Masahiro Tsuboi
A highly respected thoracic surgeon and researcher, Dr. Masahiro Tsuboi leaves behind a legacy that will continue to influence lung cancer research and patient care for years to come.
-
Leading by Example: A Message of Resilience, Gratitude, and Hope
During a special session at TTLC 2026, Dr. Ross Camidge shared his personal journey with lung cancer, discussing its impact on both his professional and personal life.
-
The Power of Team-Based Science
After being awarded the $2.5 million IASLC-LCRF grant, ILCN follows up with the research progress of Dr. David Barbie and his international team of investigators.
-
IASLC Spotlight: Q&A With the Education Committee Chair
Committee Chair Dr. Ross Soo addresses its role in supporting the IASLC’s mission of providing relevant, impactful, and timely educational content on a global scale.
-
Recognized Throughout the Cancer Advocacy World for His Red Toque, Angus Pratt Brought Lung Cancer to the Fore in Many Arenas
A real-world example of the progress that has been made in lung cancer care, ILCN editorial group member and contributor Angus Pratt survived more than seven years after his lung cancer diagnosis.
-
IASLC Spotlight: Global Policy and Partnerships Committee
In a Q&A with ILCN, Dr. Gilberto de Lima Lopes, Committee Chair, details how the committee is working to address the most significant global challenges in lung cancer care.